Sign Up to like & get
recommendations!
0
Published in 2018 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2018.08.039
Abstract: PURPOSE The objective was to assess the long-term effect of treatment with latanoprost on ocular development and safety in pediatric patients with glaucoma and ocular hypertension. DESIGN Prospective cohort study. METHODS This was a prospective…
read more here.
Keywords:
ocular hypertension;
patients glaucoma;
study;
pediatric patients ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2019.1658743
Abstract: ABSTRACT Introduction: Glaucoma refers to a heterogeneous group of optic neuropathies characterized by an enhanced intraocular pressure (IOP). To date, there are six available different drug classes for the treatment of glaucoma and ocular hypertension:…
read more here.
Keywords:
treatment glaucoma;
treatment;
rho kinase;
glaucoma ocular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2017.1346083
Abstract: ABSTRACT Introduction: Brimonidine tartrate and brinzolamide eye drops are often used as third and fourth line treatment options to reduce intraocular pressure (IOP) in the management of glaucoma and ocular hypertension. Better tolerated, more effective…
read more here.
Keywords:
brimonidine;
ocular hypertension;
safety;
glaucoma ocular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert opinion on drug safety"
DOI: 10.1080/14740338.2022.1996560
Abstract: INTRODUCTION In the last 25 years, topical prostaglandin analogues (PGAs) have emerged to become first line and first choice therapeutic options in the management of glaucoma and ocular hypertension (OHT). Although the short-term efficacy and…
read more here.
Keywords:
ocular hypertension;
safety tolerability;
safety;
tolerability ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Ophthalmology"
DOI: 10.1177/1120672118785280
Abstract: Purpose: To assess tolerability and efficacy following a switch from benzalkonium chloride–latanoprost to preservative-free latanoprost in patients with glaucoma or ocular hypertension. Methods: A total of 140 patients with glaucoma or ocular hypertension controlled with…
read more here.
Keywords:
ocular hypertension;
free latanoprost;
tolerability;
preservative free ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Drugs of today"
DOI: 10.1358/dot.2020.56.9.3178110
Abstract: Ripasudil (K-115) is a novel Rho-associated protein kinase (ROCK) inhibitor. The Rho-ROCK pathway regulates key downstream effectors involved in many cellular functions, in particular in the actin cytoskeleton activity. The clinical effects of ripasudil expected…
read more here.
Keywords:
ripasudil;
ocular hypertension;
treatment;
treatment glaucoma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24032093
Abstract: Analysis of the genotype that predicts the phenotypic characteristics of a cohort of glaucoma and ocular hypertension patients, and the correlation with their personal pharmacological response to beta-blockers (BB) and prostaglandin analogues (PGA). Prospective study…
read more here.
Keywords:
glaucoma;
hypertension patients;
glaucoma ocular;
beta blockers ... See more keywords